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THE ROLE OF THE PHOSPHOINOSITIDE
PATHWAY IN HORMONAL REGULATION
OF THE EPITHELIAL SODIUM CHANNEL
Bonnie L. Blazer-Yost and Charity Nofziger?
1.  INTRODUCTION 
 The phosphoinositide (PI) pathway, initiated by the activation of phosphatidyl-
inositol 3-kinase (PI3-kinase), forms a complex, branching signal transduction mecha-
nism involving multiple lipids and protein kinases. This pathway has been implicated in 
the regulation of a wide variety of cellular processes including inhibition of apoptosis, 
stimulation of protein synthesis, cellular trafficking, actin rearrangement, and multiple 
transport processes. The pathway can be activated either by hormone dependent or inde-
pendent signals and may be present in a constitutively active, tonic level in some cell 
types.
 Our laboratory was the first to show that the PI pathway is crucial for both aldos-
terone (steroid) and insulin (peptide) hormone stimulation of renal Na+ reabsorption.1-3
Subsequent work by us and others have solidified the importance of several of the com-
ponents of the pathway in the natriferic (Na+ retaining) actions of the hormones. 
2.  THE AMILORIDE-SENSITIVE Na+ CHANNEL
 Epithelial Na+ channels (ENaCs) are intimately involved in fluid and electrolyte 
homeostasis.  These amiloride-sensitive channels are found in the apical membrane of a 
variety of salt-absorbing epithelia and form the rate-limiting step for Na+ reabsorption. 
The importance of this channel in regulating Na+ homeostasis is underscored by the 
number of steroid and peptide hormones which directly modulate channel activity in vivo,
including aldosterone, insulin, ADH (anti-diuretic hormone), and IGF1 (insulin-like 
growth factor 1).1-8
 The primary components of the channel have been described at a molecular level.9-11
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The basic building blocks consist of homologous subunits termed ?, ?, and ????? is 
required and sufficient for transport albeit at a low level.9, 11  In the oocyte expression 
system, neither the ? nor ? subunit alone can confer Na+ transport to the oocyte. 
However, co-expression of all three subunits leads to a 10-100 fold increase in transport 
as compared to rates of transport seen with the expression of ? alone.10
 Clinically, mutations in the C-terminal region of the ? or ? subunit can cause Liddles 
syndrome, a severe form of hypertension resulting from constitutive activation of the 
renal ENaC.12, 13 Mutations in ? as well as amino acid substitutions in either the 
cytoplasmic N-terminal portion of ? or the extracellular region of ? result in pseudohypo-
aldosteronism type 1, characterized by renal salt wasting and hyperkalemic metabolic 
acidosis due to loss of channel activity.14-16 These clinical observations support the prin-
ciple that ENaC is crucial for regulation of salt and water homeostasis and that mutations 
in the channel, particularly in the cytoplasmic domains, cause serious disturbances in the 
maintenance of this delicate balance. 
 One of the most common clinical entities arising from an imbalance of salt and water 
homeostasis is essential hypertension.  Based on the findings of the most recent National 
Health and Nutrition Examination Survey (NHANES) collected from 1999-2000, 28.7% 
of the U.S. adult population had hypertension.17  This is an alarming increase compared 
to the NHANES study from 1988 through 1991 which indicated 24% of adults had 
hypertension.18  The development of essential hypertension is a multifactorial pathogenic 
process. Clearly, there are both genetic and environmental influences. However, many of 
the predisposing factors, e.g., aberrations in the renin-angiotensin-aldosterone axis; 
hyperinsulinemia, have the common result of stimulating Na+ reabsorption in the renal 
distal tubule/collecting duct via a direct effect on the ENaC. Understanding the regulatory 
mechanisms controlling ENaC activity is, therefore, an essential prerequisite to designing 
therapeutic modalities aimed at controlling disturbances in fluid and electrolyte balance 
such as hypertension. 
3.  HORMONAL REGULATION OF ENaC 
 The three hormonal systems that regulate ENaC activity in the principal cells of the 
distal nephron—aldosterone, insulin, and ADH—have additive or synergistic actions, one 
to another, on the Na+ reabsorptive transport process. Therefore, it follows that there are 
individual and distinct rate-limiting steps between receptor binding and channel 
activation.
Renal Na+ retention can be attained by increasing the density of active ENaCs in the 
apical membrane, by increasing the open probability of individual channels, or by 
altering single channel current. In all studies to date, the single channel current appears to 
vary according to the electrochemical driving forces across the apical membrane rather 
than in response to direct hormonal stimulation. Interestingly, using blocker-induced 
noise analysis, we have found that both insulin and aldosterone cause an increase in the 
number of active channels in the apical membrane with no increase in the open proba-
bility of the channel.2, 6 Previous noise analysis studies by Els and Helman have shown 
that the action of ADH also involves an increase in the number of active channels in the 
apical membrane.19 These studies are in direct contrast to those using patch clamp techn-
iques where investigators have found an increase in open probability in response to both 
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insulin and aldosterone.20, 21 Reasons for this discrepancy are not immediately obvious, 
although, there may be some contribution from the invasive nature of the patch clamp 
technique.
In order to resolve the controversy, we stably transfected green fluorescent protein 
(GFP)-tagged ENaC subunits into model renal epithelial cells and demonstrated that the 
labeled channels were indeed functional.8  Using the transfected lines, we were able to 
confirm, in the case of ADH and insulin, a movement of labeled channel from an internal 
pool into the apical plasma membrane, thus substantiating the noise analysis data.2, 6, 8
The combined data provide strong support for the contention that the actions of all three 
hormones appear to culminate in the insertion of ENaC into the apical membrane.  
Therefore, the discriminating, rate-limiting steps in the various pathways are proximal to 
the insertion reaction. 
4.  PI3-KINASE 
 The PI3-kinases are a family of enzymes which phosphorylate the D-3 position of 
the myo-inositol ring of phosphatidylinositols (PtdIns) and according to relative speci-
ficity, form PI(3)P (phosphatidylinositol-3-phosphate), PI(3,4)P2, or PI(3,4,5)P3.
22-24
These kinases have been implicated as key regulatory components of a wide variety of 
cellular processes25-32 including peptide stimulated ion transport events.29-32
With regard to transporters, PI3-kinase activity has been shown to be involved in 
insulin-stimulated insertion of vesicles containing glucose transporters (GLUT4) into the 
membranes of adipocytes27 and skeletal muscle.28  More recently, other peptide hormone-
mediated transport events have been shown to be dependent on the production of PIP3.
These include insulin-stimulated K+ uptake into fibroblasts via the Na+/K+/2Cl-
cotransporter,29 PDGF (platelet-derived growth factor) activation of the Na+/H+
exchanger,30 EGF (epidermal growth factor) stimulation of intestinal  Na+ absorption,31
and EGF-mediated inhibition of Ca2+-dependent Cl- secretion.32
 We have previously identified PI3-kinase as a regulator of basal, aldosterone- and 
insulin-stimulated Na+ flux.1-3  Hormone induced increases in the enzyme activity have 
been demonstrated in model renal cell lines, and this heightened activity is directly corre-
lated with changes in Na+ transport. Thus, the phosphoinositide pathway appears to form 
a central control point in the regulation of both peptide- and steroid-mediated natriferic 
activity (Figure 1).
Specifically, in the A6 cell culture model of the principal cells of the distal nephron, 
we have shown that stimulation with either insulin or aldosterone results in an increase of 
PIP3.  In addition, basal, insulin-stimulated and aldosterone-stimulated Na
+ transport are 
all abolished by LY294002, a specific inhibitor of PI3-kinase.1, 2 These results indicate 
that both hormones have an effect on the activity of the enzyme and that this stimulation 
of activity is necessary for insulin and aldosterone-stimulated Na+ retention. 
 The insulin results were not unanticipated because this peptide hormone is known to 
activate PI3-kinase via the insulin receptor substrate (IRS) signaling intermediate in other 
tissues.  However, the pathway stimulated in response to insulin binding in these 
polarized cells may be different than that described in non-polarized tissues. We have 
demonstrated that in response to insulin, ENaC moves from a diffuse cytoplasmic 
localization to the apical and lateral membranes.  Co-localization studies have shown that 
ENaC and PI3-kinase are not co-localized under basal conditions. Rather, the two entities 
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co-localize and are mobilized along the lateral membrane within one minute of insulin 
stimulation.3  These data indicate that insulin stimulates the migration of ENaC into the 
apical membrane and that this trafficking is dependent on PI3-kinase activity.  The details 
of the trafficking pathway remain unresolved but will be of interest because they appear 
to be mediated by a heretofore undescribed trafficking route for integral membrane 
proteins in polarized epithelial cells.
Our results with regard to the importance of PI3-kinase in aldosterone’s action were 
rather surprising.  Steroid hormone regulation of ion transport had not been previously 
linked to the PI pathway.  The aldosterone stimulated increase in PIP3 indicates that there 
is a steroid hormone-stimulated event at or before PI3-kinase which may modify the 
amount and/or activity of the enzyme.  The identification of this portion of the signaling 
pathway will be important as it is a likely site for the first rate-limiting step in 
aldosterone’s natriferic action. 
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Figure 1: Working hypothesis of the signal transduction pathway followed by natriferic hormones which 
stimulate transcellular Na+ transport in the principal cell of the mammalian distal nephron.  This theoretical 
model reflects the pathways discussed in the text.  ENaC = epithelial Na+ channel; IRS = insulin receptor 
substrate; PIP2 = phosphatidylinositol-4,5-bisphosphate; PIP3 = phosphatidylinositol-3,4,5-trisphosphate; sgk = 
serum, glucocorticoid-induced kinase; PDK = phosphatidylinositide-dependent kinase; NEDD-4 = neuronal 
precursor cell developmentally downregulated gene 4. 
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 PI3-kinase-mediated phosphorylation of the inositol headgroup of PIP2 stimulates the 
activity of the serine/threonine kinases, phosphoinositide-dependent kinases (PDK) 1 and 
2.33, 34 There are a number of substrates for the PDKs which have been identified. Several 
have been shown to be involved in transport events, particularly Akt (related to A and C 
kinase) also known as PKB (protein kinase B),33, 34 PKA (cAMP-dependent protein 
kinase A)5 and sgk (serum, glucocorticoid induced kinase).36, 37 Of these, sgk has been 
shown to be a crucial regulatory component in hormone-stimulated Na+ transport. 
5.  SGK 
 Sgk, Akt and PKA all belong to the same “family” of serine/threonine kinases linked 
by a structural similarity in the kinase domain, particularly the activation loop.  Within 
the activation loop, PDK1 phosphorylation of a key threonine residue is necessary for 
enzyme activation.  The particular motif defining the single PDK1 phosphorylation site is 
common to these three serine/threonine kinases.3, 35-37 Phosphorylation of these substrates 
by PDK2 on a serine residue outside the activation loop appears to have a permissive 
effect on activity. 
 Of the PDK substrates, sgk is potentially the most interesting because it has been 
shown to be an aldosterone-induced protein in A6 epithelia38 and rat cortical collecting 
ducts.39 This kinase is regulated by multiple factors including serum, steroid hormones 
and cell volume changes. When the mRNAs for sgk and ENaC are co-expressed in 
oocytes, the ENaC activity is potentiated several-fold.38, 39
 It has been demonstrated that sgk does not phosphorylate the channel per se. 
Interestingly, however, one of the substrates for the enzyme is an ENaC regulatory pro-
tein, a ubiquitin ligase termed Nedd4-2 (neural precursor cell-expressed, developmentally 
downregulated gene 4, isoform 2).40-42  Nedd4-2 has been shown to be an ENaC partner 
in a two hybrid system.41 The ubiquitin ligase contains WWW domains which bind the 
highly conserved proline-rich PY (proline-tyrosine) motifs in the carboxyl termini of 
ENaC subunits. In the kidney, Nedd4-2 has been immunolocalized to the cortical 
collecting tubules and outer and inner medullary collecting ducts.42 Nedd4-2 appears to 
be a negative regulator of ENaC which ubiquitinates the channel, thereby targeting it for 
endocytosis and, presumably, degradation. Sgk phosphorylation of Nedd4-2 inhibits the 
binding of this ubiquitin ligase to the channel, resulting in increased channel expression 
in the apical membrane.40, 43-45  While expression of Nedd4-2 is not altered by elevations 
of serum aldosterone,42 sgk which can negatively modulate its activity is an aldosterone-
induced protein.  The role of sgk in this portion of the pathway could be envisioned as an 
inhibitor of the “turn-off” mechanism of aldosterone’s action.
It is possible that sgk may play additional roles in the natriferic action of both steroid 
and peptide hormones. In native, Na+ transporting epithelial cells (A6 cell line), we have 
supplemented the endogenous sgk by stably transfecting with either wt or mutated 
enzyme and have used the resultant cell lines to show that sgk plays a role in basal as 
well as insulin-, ADH- and aldosterone-stimulated Na+ transport.46 The enzyme is 
required for basal and hormone-stimulated transport; a dominant negative form of the 
kinase abolishes all transepithelial Na+ flux. Expression of additional wt sgk results in a 
potentiated response to ADH indicating that the enzyme is rate-limiting for this natriferic 
response. In contrast, the enzyme, while necessary, does not appear to be rate-limiting for 
insulin- or aldosterone-stimulated Na+ transport.46 These studies are in agreement with a 
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mouse sgk knock-out model demonstrating a milder phenotype than the corresponding 
ENaC or mineralocorticoid receptor knockout animals.47
 Our results from the transfection studies have been substantiated by others who have 
reached the similar conclusion that sgk may also play a role in the initial steps of 
hormonal stimulation, possibly by mediating channel insertion into the membrane.48 In 
the search for a mechanism of the action of sgk in the initial steps of Na+ channel 
activation, several intriguing clues have emerged. Alvarez de la Rosa and colleagues have 
found that in rat kidney, sgk1, the predominant isoform of the distal tubular cells, is 
expressed in relatively high amounts under basal conditions with little fluctuation in 
response to physiological concentrations of aldosterone.49Sgk, a protein with no 
membrane spanning domains, was found associated with the microsomal fraction in 
tissue homogenates. Furthermore, sgk co-localized with Na+,K+-ATPase in immuno-
histochemical studies.49 These results suggest that sgk may be part of a complex found 
predominately on the basolateral membrane rather than on the apical membrane where 
sgk would be localized to regulate the ENaC/Nedd4-2 interaction.
As noted above, we have recently found that within one minute of insulin 
stimulation, ENaC moves first to the vicinity of the lateral membranes where it co-
localizes with PI3-kinase, an enzyme that initiates a kinase cascade which can result in 
the activation of sgk.  Subsequently, the ENaC enters the apical membrane. If the activity 
of PI3-kinase is inhibited with LY294002, ENaC and PI3-kinase still undergo an insulin-
mediated co-localization but are not trafficked to the lateral membrane, and ENaC does 
not enter the apical membrane.3  Given the sgk localization results cited above, it could 
be speculated that the entire PI pathway may be assembled in a complex close to the 
basolaterally-located peptide hormone receptors which initiate the natriferic signal. 
Confirmation of this speculation awaits experimental verification.
6.  INTERACTION BETWEEN THE PHOSPHOINOSITIDE AND cAMP/PKA    
 PATHWAYS  
Biochemical pathways besides the PI pathway are capable of modulating changes in 
Na+ reabsorption via ENaC. For example, ADH stimulates the cAMP/PKA signaling cas-
cade via binding to a V2 receptor on the basolateral membrane of renal epithelial cells, 
thereby stimulating adenylate cyclase and the production of cAMP.  The increased cAMP 
in turn activates PKA. The end result of the hormone-receptor binding is a decrease in 
Na+ excretion but the post-PKA activation steps of the pathway remain unknown.
As cited above, sgk appears to be the rate-limiting step in ADH-mediated Na+
reabsorption.46 Therefore, it is likely that the cAMP and PI pathways intersect. There are 
several plausible sites for this potential interaction. PKA and sgk are each substrates for 
PDK1 and 2.50, 51 Thus, PKA could theoretically be modulated by the PI pathway in the 
absence of cAMP induction.
Alternatively, in the absence of PI3-kinase, the PKA pathway may activate 
downstream elements of the PI pathway.  Sgk contains a PKA consensus sequence and 
Perrotti et al., have shown that 8-(4-chlorophenylthio)-cAMP caused a two-fold 
activation of sgk expressed in COS7 cells,52 indicating that cAMP can regulate sgk 
independently of PI3-kinase. This would be consistent with our observations that 
stimulation of A6 cells with ADH leads to an apparent potentiated response (measured as 
an increase in transport) if the PI3-kinase pathway has been inhibited by LY294002.53
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One possible explanation for this finding is that the increased PKA activity could restore 
the sgk activity.
PKA and sgk can also phosphorylate the same substrate. Both kinases have been 
shown to regulate the ROMK channel, a K+ leak channel activated in response to 
aldosterone stimulation, thereby causing it to be redistributed from the endoplasmic 
reticulum to the plasmolemma.54  Based on the latter findings, it would be reasonable to 
postulate that sgk and PKA may act on a novel, common substrate upstream of ENaC.
Clearly, the cAMP/PKA and PI pathways intersect. In model renal epithelial cells, 
both pathways regulate transepithelial Na+ transport.  Determining the site(s) of such 
complex interactions will require a melding of biochemical, electrophysiological, 
molecular and histological approaches. 
7.  SUMMARY
 In summary, insulin and aldosterone stimulate phosphatidylinositol phosphorylation, 
thus indicating the existence of a regulated protein at or before the PI3-kinase step.1-5
Aldosterone induces the synthesis of sgk, a downstream element of the PI pathway. Sgk 
is necessary, but not rate-limiting, for aldosterone- and insulin-stimulated Na+ transport.
However, the enzyme appears to be rate-limiting for the natriferic action of ADH. 
Insulin-stimulated Na+ transport, an acute response, is dependent on PI3-kinase activity 
but the magnitude of the response is not altered by a cellular excess of sgk. ADH- 
stimulated transport is not dependent on PI3-kinase but is potentiated by an excess of sgk. 
The foregoing data indicate that the PI pathway is involved in several steps of the 
natriferic action of hormones and intersects with other pathways which regulate ENaC. 
Furthermore, the data are consistent with the hypothesis that activation of PI3-kinase may 
ultimately stimulate channel insertion as well as regulate channel endocytosis. Both of 
these phenomena can result in an increase of ENaC-mediated Na+ transport.
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